We don’t often discuss individual stocks, either in our practice or in these pages. So when we dedicate our Chart Of The Day to a…
There is a fervent debate in some financial circles regarding the existence – or non-existence – of a biotech bubble. It is a challenging, and…
We’ve written about divergences in breadth (i.e., advancing issues vs. declining issues) on several occasions in the past. These such posts have included breadth divergences…
Over the past few years, the U.S. has borne much of the weight in terms of global equities. Except for India and just recently, China,…
Oil Services Sector Treading Major Support Level After being bludgeoned in the back half of 2014 (to the tune of -35%) along with all oil-related…
Some days, the stock market soars at the expense of bonds. Other days, it is commodities like oil or gold that shine. And some days,…
Some days, the stock market soars at the expense of bonds. Other days, it is commodities like oil or gold that shine. And some days,…
The news coverage of the weakness in the Euro has been incessant. It has been completely justified, however, considering the currency’s plunge has been equally…
In a January 20 post titled “European Stocks Set To Blast Higher?”,we pointed out a potential major breakout in the broad Dow Jones Stoxx Europe…
While they may forever be inexorably linked together, not all PIIGS are the same. By PIIGS (i.e., Portugal, Ireland, Italy, Greece and Spain), we are…